Environmental influence on the worldwide prevalence of a 776C→G variant in the transcobalamin gene (TCN2)
- Jean-Louis Guéant1,
- Nicodème W Chabi4,
- Rosa-Maria Guéant-Rodriguez1,
- Osvaldo M Mutchinick2,
- Renée Debard1,
- Corinne Payet1,
- Xiaohong Lu1,
- Christian Villaume1,
- Jean-Pierre Bronowicki1,
- Edward V Quadros3,
- Ambaliou Sanni4,
- Emile Amouzou5,
- Bing Xia6,
- Min Chen6,
- Guido Anello7,
- Paolo Bosco7,
- Corrado Romano7,
- Heidy R Arrieta2,
- Beatríz E Sánchez2,
- Antonino Romano8,
- Bernard Herbeth9,
- Wafaa Anwar10,
- Fares Namour1
- 1Inserm U-724, Cellular and Molecular Pathology in Nutrition, Faculté de Médecine, University Henry Poincaré of Nancy, Vandoeuvre lès Nancy, France
- 2Departamento de Genética, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico city, México
- 3Department of Biochemistry, SUNY-Downstate Medical Center, Brooklyn, New York, USA
- 4Laboratory of Biochemistry and Molecular Biology, Université de Cotonou, Bénin
- 5Laboratory of Biochemistry and Nutrition, Lomé, Togo
- 6Department of Internal Medicine and Geriatrics, Zhongnan Hospital and Research Center of Digestive Diseases, Wuhan University Medical School, Wuhan, PR China
- 7IRCCS, Oasi Maria SS–Institute for Research on Mental Retardation, Troina (EN), Italy
- 8Department of Internal Medicine and Geriatrics, UCSC, CI Columbus, Roma, Italy
- 9Inserm U525, Nancy, France
- 10Département de Biologie, Faculté de Médecine, Casablanca, Morocco
- Correspondence to: Professor J-L Guéant Inserm U-724, Cellular and Molecular Pathology in Nutrition, Faculté de Médecine, University Henry Poincaré of Nancy, BP 184, 54500, Vandoeuvre lès Nancy, France; jl.gueant{at}chu-nancy.fr
- Received 29 November 2006
- Accepted 4 January 2007
- Revised 3 January 2007
- Published Online First 12 January 2007
Abstract
Background: A 776C→G variant (dbSNP ID: rs1801198) in the transcobalamin gene (TCN2; MIM# 275350) decreases the cellular and plasma concentration of transcobalamin and thereby influences the cellular availability of vitamin B12.
Objective: To evaluate the worldwide prevalence of this variant and its association with homocysteine plasma level.
Methods: The study was performed in 1433 apparently healthy subjects, including Afro-Americans and Afro-Africans and in 251 Afro-Africans participants with severe malaria.
Results: The frequencies of the 776G allele were the highest in China (0.607; 95% CI 0.554 to 0.659), low in West Africa (Bénin and Togo, 0.178; 0.154 to 0.206), and intermediate in France (0.445; 0.408 to 0.481), Italy (0.352; 0.299 to 0.409), Morocco (0.370; 0.300 to 0.447) and Mexico (0.374; 0.392 to 0.419). The 776G genotype was more frequent in Afro-Americans from New York (16.7; 8.4 to 30.7) and in Afro-African patients with severe malaria (6.0%; 95% CI 3.7 to 9.6) than in healthy Afro-African volunteers (p = 0.0004 and p = 0.033, respectively), while no difference was observed for MTHFR 677TT and 677T alleles. A disequilibrium of TCN2 genotype distribution was recorded in patients with severe malaria, with a twofold higher GG genotype than expected (p = 0.010). An association between the TCN2 polymorphism and homocysteine was observed only in Mexico and France, the two countries with the highest rate of low plasma concentration of vitamin B12 (<100 pmol/l).
Conclusion: Given the dramatic heterogeneity of the 776G allele frequency worldwide, this polymorphism may be prone to a selective pressure or confers an evolutionary advantage in confronting environmental factors, one of which is malaria.
Footnotes
-
Published Online First 12 January 2007
-
Competing interests: None.








